Stay updated on Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial page.

Latest updates to the Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page revision shows v3.5.4, replacing the previous v3.5.3. This indicates a minor update to the page's versioning metadata rather than changes to study details.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThis reflects a minor ClinicalTrials.gov site/UI release update (revision label changed to v3.5.3) without changing the study details themselves.SummaryDifference0.0%

- Check47 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check69 days agoChange DetectedAdded Carcinosarcoma of the corpus uteri as an associated condition reference and included a link to the Genetic and Rare Diseases Information Center in the Resources section.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page revision label was updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check91 days agoChange DetectedA new site revision v3.4.3 was added and the previous revision v3.4.2 was removed.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial page.